Medtronic plc announced that it received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy defibrillators (CRT-Ds) approved for 3 Tesla (T) magnetic resonance imaging (MRI) scans.

Boston Scientific announced in late February that the Eluvia Drug-Eluting Vascular Stent System received CE Mark, and is commencing commercialization immediately in the European Union and other countries where CE Mark is recognized.

Clarius Mobile Health is showcasing a new handheld ultrasound scanner with a mobile application for iOS and Android smart devices at the American Institute of Ultrasound in Medicine Conference in New York, March 18-21.

A recent study is bringing new hope to families of children who struggle with a common form of leukemia and thus must confront an elevated risk for long-term heart ailments caused by chemotherapy.

The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a research study evaluating a potential new treatment for patients with symptomatic persistent and long standing persistent atrial fibrillation (AFib).

Bioengineers and physicians at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs. The new therapy could prevent or limit amputations for a condition that affects more than 27 million people and is a manifestation of advanced peripheral arterial disease.

A team of researchers led by the University of Missouri School of Medicine has developed a new, real-time method of imaging molecular events after ischemic strokes ― a finding that may lead to improved care for patients.

While there are constant advances in cardiac technologies, it is rare when one of these new ideas may rapidly challenge the standard of care in a very short period of time.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now